The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome

被引：0
作者：
Sarah Brown
Nuria Navarro Coy
Costantino Pitzalis
Paul Emery
Sue Pavitt
Janine Gray
Claire Hulme
Frances Hall
Robert Busch
Pete Smith
Luke Dawson
Michele Bombardieri
Ng Wan-fai
Colin Pease
Elizabeth Price
Nurhan Sutcliffe
Clodagh Woods
Sharon Ruddock
Colin Everett
Catherine Reynolds
Emma Skinner
Ana Poveda-Gallego
John Rout
Iain Macleod
Saaeha Rauz
Simon Bowman
机构：
[1] University of Leeds,Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research
[2] University of Leeds,Leeds Institute of Rheumatic and Musculoskeletal Medicine
[3] Queen Mary University of London,Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts & The London
[4] University of Cambridge,Department of Clinical Medicine
[5] University of Liverpool,School of Dental Sciences
[6] NIHR Leeds Musculoskeletal Biomedical Research Unit,Academic Unit of Health Economics, Leeds Institute of Health Sciences
[7] Leeds Teaching Hospitals NHS Trust,Centre for Health Sciences Research, Leeds Institute of Health Sciences
[8] University of Leeds,Musculoskeletal Research Group
[9] University of Leeds,Academic Unit of Ophthalmology, Centre for Translational Inflammation Research
[10] University of Newcastle,Department of Life Sciences
[11] Chapel Allerton Hospital,Arthritis Research UK Primary Care Centre, Primary Care Services
[12] Great Western Hospital,undefined
[13] Royal London Hospital (Mile End),undefined
[14] TRACTISS PPI representative,undefined
[15] c/o Chapel Allerton Hospital,undefined
[16] Birmingham Dental Hospital,undefined
[17] St Chad’s Queensway,undefined
[18] Newcastle Dental Hospital & School,undefined
[19] University of Birmingham,undefined
[20] University of Roehampton,undefined
[21] Whitelands College,undefined
[22] Holybourne Ave,undefined
[23] University of Keele,undefined
[24] New Queen Elizabeth Hospital,undefined
[25] Mindelsohn Way,undefined
[26] Edgbaston,undefined
来源：
BMC Musculoskeletal Disorders | / 15卷
关键词：
Sjögren’s syndrome; Rituximab; Anti-B-cell; Double-blind; Placebo; Trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 60 条
  • [1] Vitali C(2002)Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 61 554-558
  • [2] Bombardieri S(2004)Estimating the prevalence among Caucasian women of primary Sjögren’s syndrome in two general practices in Birmingham UK Scand J Rheumatol 33 39-43
  • [3] Jonsson R(1998)Sjögren's syndrome: a community-based study of prevalence and impact Br J Rheumatol 37 1069-1076
  • [4] Bowman SJ(2004)UK Sjögren’s interest group. Measurement of fatigue and discomfort in primary Sjögren’s syndrome using a new questionnaire tool Rheumatology 43 758-764
  • [5] Ibrahim GH(2007)Safety and efficacy of Rituximab in Sjögren’s syndrome: results of a randomised, placebo controlled trial Ann Rheum Dis 66 70-317
  • [6] Holmes G(2008)Rituximab treatment in primary Sjögren’s syndrome: a double-blind placebo controlled trial ACR 58 713-2750
  • [7] Hamburger J(2007)Improvement of Sjögren’s syndrome after two infusions of Rituximab (anti-CD20) Arthritis Care Res 57 310-357
  • [8] Ainsworth JR(2005)Rituximab treatment in patients with primary Sjögren’s syndrome: an open-label phase II study Arthritis Rheum 52 2740-1477
  • [9] Thomas E(2007)Tolerance and efficacy of Rituximab and changes in serum B-cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome Ann Rheum Dis 66 351-703
  • [10] Hay EM(2007)Longitudinal analysis of lymphocyte subsets in patients with primary Sjögren’s syndrome (PSS) treated with hRituximab. Results from an open-label clinical trial Arthritis Rheum 56 S445-39
123456